North America Insulin Delivery Devices Market, By Product Type (Insulin Pens, Insulin Pumps, Pen Needles, Insulin Syringes, Insulin Injectors, Others), Application (Type I Diabetes, Type II Diabetes), End User (Hospitals and Clinics, Homecare, Specialty Centers), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/Centers), Country (U.S., Mexico, Canada) Industry Trends and Forecast to 2029.
Market Analysis and Insights : North America Insulin Delivery Devices Market
Data Bridge Market Research analyses that the North America insulin delivery devices market to be grow at a CAGR of 7.85% in the forecast period of 2022-2029.
Insulin is an important aspect of the treatment plan for all persons with diabetes both type 1 and type 2. Insulin pens, syringes, jet injectors and insulin pumps are used to inject the insulin delivery device directly into the fatty tissues beneath the skin.
One of the major reasons likely to boost the growth and demand of the insulin delivery devices market is the favourable reimbursement environment and government support in certain countries. The rise in the diabetic population and technological improvements in insulin delivery devices, are expected to propel the global insulin delivery devices market forward. Similarly, the launch of seminars, conferences, and congresses to raise awareness about insulin delivery devices is expected to boost market growth. Furthermore, the collaboration of the public and private sectors to satisfy diabetes needs, as well as advantageous device insurance and reimbursement policies, are projected to contribute to the market's growth.
Moreover, increase in research and development efforts, the rise in healthcare expenses and diabetes-related health expenditure in emerging nations, are fueling plenty of opportunities that will propel the insulin delivery devices market forward over the projection period.
However, poor reimbursement structures, and other problems linked to the reuse of pen needles and infusion sets, are expected to hinder the growth of the insulin delivery devices market, whilst a severe lack of endocrinologists, and stringent government regulations and product approvals, are just a few of the challenges that could stymie the insulin delivery devices market's growth.
This North America insulin delivery devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on North America insulin delivery devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Insulin Delivery Devices Market Scope and Market Size
North America insulin delivery devices market is segmented on the basis of product type, application, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the insulin delivery devices market is segmented into insulin pens, insulin pumps, pen needles, insulin syringes, insulin injectors and others. Insulin pens segment is further sub-segmented into reusable insulin pens and disposable insulin pens. Insulin pumps segment is further sub-segmented into external/tethered pumps and patch pumps. Pen needles segment is further sub-segmented into standard pen needles and safety pen needles.
- The insulin delivery devices market can is segmented on the basis of application into type I diabetes and type II diabetes.
- The end user segment of the insulin delivery devices market is segmented into hospitals and clinics, homecare and specialty centers.
- Based on distribution channel, the insulin delivery devices market is segmented into hospital pharmacy, retail pharmacy, online sales and diabetes clinics/centers.
North America Insulin Delivery Devices Market Country Level Analysis
North America insulin delivery devices market is analysed and market size insights and trends are provided by country, product type, application, end user and distribution channel as referenced above.
The countries covered in the North America insulin delivery devices market report are Germany, France, U.K., Italy, Spain, Russia, Netherland, Switzerland, Turkey, Austria, Belgium, and Rest of North America.
United States dominate the North America insulin delivery devices market and will continue to flourish its trend of dominance during the forecast period due to presence of several pharmaceuticals as well as biotechnology firms, increasing incidence of chronic diseases such as obesity and diabetes and increased government measures to develop healthcare infrastructure in this region.
The country section of the North America insulin delivery devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The North America insulin delivery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America insulin delivery devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America insulin delivery devices market. The data is available for historic period 2010 to 2020.
Competitive Landscape and North America Insulin Delivery Devices Market Share Analysis
The North America insulin delivery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to North America insulin delivery devices market.
Some of the major players operating in the North America insulin delivery devices market are Johnson & Johnson Private Limited, Medtronic, F Hoffmann-La Roche Ltd., BD, Novo Nordisk AS, Sanofi, B. Braun Melsungen AG, Ypsomed AG, Eli Lilly and Company, Biocon, WOCKHARDT, Biodel Inc., Insulet Corporation, Tandem Diabetes Care, Inc., among others.
SKU-